期刊文献+

非心脏手术中大剂量羟乙基淀粉130/0.4容量治疗的可行性 被引量:1

原文传递
导出
摘要 羟乙基淀粉(HES)已广泛应用于容量治疗,可有效地维持血管内容量和组织灌注,其扩容效应和副作用与分子量及取代级有关^[1]。HES可抑制凝血功能,且大剂量HES有血液稀释效应^[2],在机体内经肝脏代谢后从肾脏清除^[3],因此输注大剂量HES可能损害肾功能,目前临床推荐6%HES 130/0.4的每日最大剂量为33ml/kg,但由于其分子量和取代级降低,安全性进一步提高。有研究表明重症颅脑损伤患者每日给予6%HES 130/0.4(70ml/kg)具有良好的安全性^[4]。本研究拟评价非心脏手术中大剂量(50ml/kg)6%HES 130/0.4的安全性和有效性。
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2008年第7期663-665,共3页 Chinese Journal of Anesthesiology
  • 相关文献

参考文献10

  • 1Lang K, Boldt J, Suttner S, et al. Colloids verus erystalloids and tissue oxygen tension in patitents undergoing major abdominal surgery. Anesth Aalg, 2001, 93. 405-409.
  • 2Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, et al. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg,2006, 102: 998-1006.
  • 3Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 ( 6%, 500ml ) in mild-to-severe renal impairment. Anesth Analg, 2002, 95: 544-551.
  • 4Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg, 2003, 96: 1453-1459.
  • 5Van der Linden PJ, De Herr SG, Daper A, et al. 3.5% urealinked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth,2004, 51:236-241.
  • 6Nielsen VG. Colloids decrease clot propagation and strength: role of factor Ⅷ-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand, 2005,49 : 163-171.
  • 7Niemi TT, Kuitunen A. Artificial colloids impair haemostasis, An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand,2005, 49: 373-378.
  • 8Haisch G, Boldt J, Krebs C, et al. Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth ,2001, 15: 3163-3121.
  • 9张国庆,李悦,李轶聪,关秀茹,冯磊光.6%羟乙基淀粉急性超容性血液稀释对开胸手术患者围术期肾功能的影响[J].中华麻醉学杂志,2004,24(6):422-424. 被引量:13
  • 10Kasper SM, Meinert P, Kampe S, et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended dose. Anesthesiology, 2003, 99: 42-47.

二级参考文献5

共引文献12

同被引文献9

  • 1Tian J,Lin X,Guan R,et al.The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms.Anesth Analg,2004,98(3):768-744.
  • 2Lank K,Suttner S,Boldt J,et al.Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery.Can J Anaesth,2003,50(10),1009-1016.
  • 3Boldt J,Ducke M,Kumle B,et al.Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery.Intensive Care Med,2004,30(3):416-422.
  • 4Handrigan MT,Bums AR,Doimachie EM,et al.Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration.Shock,2005,24(5):434-439.
  • 5Wiggers WC,Ingraham BC.Hemorrhage shock:definition and criteria for its diagnosis.J Clin Invest,1946,25(1):30-36.
  • 6Neff TA,Doelberg M,Wargenau M,et al.Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury.Anesth Analg,2003,96(5):1453-1459.
  • 7Diehl KH,Hull R,Morton D,et al.A good practice guide to the administration of substances and removal of blood,including routes and volumes.J Appl Toxicol,2001,21 (1):15-23.
  • 8Dillon J,Lynch LJ,Myers R,et al.A bioassay of treatment of hemorrhagic shock.Arch Surg,1966,93(7):537-555.
  • 9陈畅,王焱林,王成夭,张宗泽.Toll样受体4在失血性休克复苏致小鼠急性肺损伤中的作用[J].中华麻醉学杂志,2008,28(9):820-823. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部